Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001050007-17-000021
Filing Date
2017-04-27
Accepted
2017-04-27 16:37:47
Documents
50
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nutr-33117x10q.htm 10-Q 570507
2 EXHIBIT 31.1 nutr-ex311x33117.htm EX-31.1 24492
3 EXHIBIT 32.1 nutr-ex321x33117.htm EX-32.1 10765
10 NUTRA LOGO g604248.jpg GRAPHIC 15105
  Complete submission text file 0001050007-17-000021.txt   2895542

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nutr-20170331.xml EX-101.INS 439509
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nutr-20170331.xsd EX-101.SCH 23525
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nutr-20170331_cal.xml EX-101.CAL 57751
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nutr-20170331_def.xml EX-101.DEF 95569
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nutr-20170331_lab.xml EX-101.LAB 359032
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nutr-20170331_pre.xml EX-101.PRE 189897
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

EIN.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 17789657
SIC: 2833 Medicinal Chemicals & Botanical Products